While the hallmark of SCD lies in the presence of the hemoglobin S (HbS) variant, it is increasingly recognized that the genetic landscape extends beyond the hemoglobin subunit beta (HBB) gene, with various genetic modifiers exerting considerable influence on the clinical phenotype of affected individuals. The gene discussed is HBB; the disease is Schnyder corneal dystrophy.